Duchenne muscular dystrophy

被引:208
|
作者
Yiu, Eppie M. [1 ,2 ,3 ,4 ]
Kornberg, Andrew J. [1 ,3 ,4 ]
机构
[1] Royal Childrens Hosp Melbourne, Dept Neurol, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Bruce Lefroy Ctr, Melbourne, Vic, Australia
[3] Univ Melbourne, Neurosci Res, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
corticosteroid; Duchenne; gene therapy; muscular dystrophy; non-invasive ventilation; positive pressure; HOME NOCTURNAL VENTILATION; CORTICOSTEROID TREATMENT; BECKER; SCOLIOSIS; SURVIVAL; CARRIERS; ANESTHESIA; MANAGEMENT; DISORDERS; SPECTRUM;
D O I
10.1111/jpc.12868
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Duchenne muscular dystrophy, an X-linked disorder, has an incidence of one in 5000 boys and presents in early childhood with proximal muscle weakness. Untreated boys become wheelchair bound by the age of 12 years and die of cardiorespiratory complications in their late teens to early 20s. The use of corticosteroids, non-invasive respiratory support, and active surveillance and management of associated complications have improved ambulation, function, quality of life and life expectancy. The clinical features, investigations and management of Duchenne muscular dystrophy are reviewed, as well as the latest in some of the novel therapies.
引用
收藏
页码:759 / 764
页数:6
相关论文
共 50 条
  • [31] Adults with Duchenne Muscular Dystrophy
    Eagle, Michelle
    Straub, Volker
    Bushby, Kate
    NEUROMUSCULAR DISORDERS, 2006, 16 : S120 - S120
  • [32] Challenges in Duchenne muscular dystrophy
    Davies, KE
    NEUROMUSCULAR DISORDERS, 1997, 7 (08) : 482 - 486
  • [33] Osteopontin in Duchenne Muscular Dystrophy
    Pegoraro, Elena
    Bello, Luca
    Piva, Luisa
    Barp, Andrea
    Ermani, Mario
    Politano, Luisa
    Mercuri, Eugenio
    Previtali, Stefano
    Torrente, Yvan
    Bruno, Claudio
    Minetti, Carlo
    Berardinelli, Angela
    Comi, Giacomo
    D'Amico, Adele
    Soraru', Gianni
    Messina, Sonia
    Mongini, Tiziana
    Bertini, Enrico
    Ferlini, Alessandra
    Gualandi, Francesca
    Battini, Roberta
    Boffi, Patrizia
    Pane, Marika
    Vita, Giuseppe
    Hoffman, Eric
    Angelini, Corrado
    NEUROLOGY, 2012, 78
  • [34] Duchenne muscular dystrophy and epilepsy
    Costa, L. M.
    Barcelos, B. C.
    Cruz, A. R. S.
    Pereira, V. B. P.
    Godoy, A. J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S300 - S300
  • [35] Theragnosis for Duchenne muscular dystrophy
    Carcione, M.
    Luce, L.
    Mazzanti, C.
    Mesa, L.
    Dubrovsky, A.
    Corderi, J.
    Giliberto, F.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S83 - S83
  • [36] Biomarkers in Duchenne Muscular Dystrophy
    Lee-Gannon, Theo
    Jiang, Xuan
    Tassin, Tara C.
    Mammen, Pradeep P. A.
    CURRENT HEART FAILURE REPORTS, 2022, 19 (02) : 52 - 62
  • [37] Update on Duchenne muscular dystrophy
    Leiva-Cepas, F.
    Montano Martinez, A.
    Lopez-Lopez, I
    MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (07): : 472 - 481
  • [38] Casimersen for Duchenne muscular dystrophy
    Wilton-Clark, H.
    Yokota, T.
    DRUGS OF TODAY, 2021, 57 (12) : 707 - 717
  • [39] Biomarkers in Duchenne Muscular Dystrophy
    Theo Lee-Gannon
    Xuan Jiang
    Tara C. Tassin
    Pradeep P. A. Mammen
    Current Heart Failure Reports, 2022, 19 : 52 - 62
  • [40] Golodirsen for Duchenne muscular dystrophy
    Anwar, S.
    Yokota, T.
    DRUGS OF TODAY, 2020, 56 (08) : 491 - 504